January 9th 2023
Evusheld, the only FDA-approved COVID-19 pre-exposure prophylactic, is anticipated to be ineffective against the emerging XBB.1.5 variant.
Seeking Solutions for Endocarditis in People Who Inject Drugs
March 7th 2022“People don’t recognize that at least 1 in 5 of the deaths from opioids may result from endocarditis,” said National Institute of Drug Abuse (NIDA) director Dr. Nora Volkow, adding that endocarditis is “100% preventable.”
Read More
Johnson & Johnson Report Promising COVID-19 Vaccine Booster Efficacy, Long-Term Data
September 21st 2021Preprint data from a real-world evidence assessment, as well as preliminary reports from a 2-dose trial, support the company's pursuit for FDA authorization of a second COVID-19 vaccine dose.
Read More